Analyst Report: Axsome Therapeutics, Inc. (AXSM) - Buy
Professional analyst consensus for Axsome Therapeutics, Inc. ($AXSM)
Analyst Consensus: • Rating: Buy
• Analysts Coverage: 17 analysts
• Price Target: $310.0
• Potential Upside: ↗️ 40.3%
Market Cap: 11.4B
Key Insights: Needham maintains a Buy rating on Axsome Therapeutics with a $268 price target, citing robust market potential in CNS therapies and a 34% YoY prescription growth for Auvelity, reflecting strong adoption. The overall stance is bullish.
Posted Aug 11, 2026, 11:17 AM UTC
10